Appropriateness of theophylline plasma levels

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 8, 2007, Pages 1166-

  Lippi, Giuseppe ^a   Salvagno, Gian Luca ^a   Brocco, Giorgio ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THEOPHYLLINE;

ASTHMA; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG MONITORING; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INDIVIDUALIZATION; ITALY; LETTER; MAJOR CLINICAL STUDY; OUTPATIENT; STATISTICAL ANALYSIS; TEACHING HOSPITAL;

BRONCHODILATOR AGENTS; DRUG MONITORING; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; OUTPATIENTS; OVERDOSE; THEOPHYLLINE;

EID: 34547893825     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Howanitz PJ, Steindel SJ. Digoxin therapeutic drug monitoring practices: a College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels. Arch Pathol Lab Med. 1993;117:684-690.
2. Pesce AJ, Rashkin M, Kotagal U. Standards of laboratory practice: theophylline and caffeine monitoring. National Academy of Clinical Biochemistry. Clin Chem. 1998;44:1124-1128.
3. Hendeles L, Massanari M, Weinberger M. Update on the pharmacodynamics and pharmacokinetics of theophylline. Chest. 1985;88:103S-111S.
4. Bredon JW, Bootman JL, Jones WN, McGhan WF, Perrier DG, Campbell SC. Theophylline serum concentrations in ambulatory patients with chronic obstructive pulmonary disease. Ther Drug Monit. 1985;7:168-173.
5. Sargenti C, Zelman L, Beauclair T, Garrard E. Evaluation of appropriateness and interpretation of serum theophylline assays. Drug Intell Clin Pharm. 1985;19:380-384.